Senior Financial Analyst
Novartis
Jun 2022 - Nov 2023 (1 year 6 months)
Here I was leading Financial Planning and Analysis for the Singapore Site, where I have been entrusted with crucial responsibilities such as Capital Appropriation Request (CAR), MBR analysis, LF1 and LF2 forecasting, Impairment Review, FTE reconciliation, and assets activation & write-off. I was responsible for ensuring the quality of requested analyses, as well as the quality of comments on the drivers of actual performance and deviations vs. plans, in addition to the timeliness and completeness of data submissions. My role extended to managing depreciation and personnel costs for the entire SG site. Moreover, I was functioning as a Finance Business Partner, deeply involved in analyzing, planning, reporting, and monitoring the function's f